Pharmaceuticals & Manufacturing

Thumbnail for NICE approves Ryeqo for endometriosis treatment in the UK

14 March 2025

NICE approves Ryeqo for endometriosis treatment in the UK

Thumbnail for Bristol Myers Squibb to acquire 2seventy bio in US$286M deal

14 March 2025

Bristol Myers Squibb to acquire 2seventy bio in US$286M deal

Thumbnail for Zealand Pharma secures US$5.3B deal with Roche for obesity treatment

14 March 2025

Zealand Pharma secures US$5.3B deal with Roche for obesity treatment

Thumbnail for Novo Nordisk announces positive Phase 3 results for CagriSema

13 March 2025

Novo Nordisk announces positive Phase 3 results for CagriSema

Thumbnail for DFIs unite to boost African Pharmaceutical Manufacturing Post-Cairo Forum

12 March 2025

DFIs unite to boost African Pharmaceutical Manufacturing Post-Cairo Forum

Thumbnail for Sun Pharma to acquire Checkpoint Therapeutics for US$355M

11 March 2025

Sun Pharma to acquire Checkpoint Therapeutics for US$355M

Thumbnail for Orbis Medicines welcomes Mikael Dolsten as Board Chair

5 March 2025

Orbis Medicines welcomes Mikael Dolsten as Board Chair

Thumbnail for CFAO Healthcare to acquire full stake in Goodlife Pharmacy Chain

4 March 2025

CFAO Healthcare to acquire full stake in Goodlife Pharmacy Chain

Thumbnail for Genentech adds TNKase to stroke treatment portfolio with FDA approval

4 March 2025

Genentech adds TNKase to stroke treatment portfolio with FDA approval

Thumbnail for Boehringer Ingelheim launches revolutionary stroke treatment in UAE

3 March 2025

Boehringer Ingelheim launches revolutionary stroke treatment in UAE